Cargando…
Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in Japan
Background: Recent revisions of clinical guidelines by the Japanese Circulation Society, American Heart Association/American College of Cardiology, and European Society of Cardiology updated the management of antithrombotic strategies for patients with atrial fibrillation (AF) undergoing percutaneou...
Autores principales: | Nakano, Yasuhiro, Matoba, Tetsuya, Yamamoto, Mitsutaka, Katsuki, Shunsuke, Koga, Yasuaki, Mukai, Yasushi, Inoue, Shujiro, Suematsu, Nobuhiro, Higo, Taiki, Takemoto, Masao, Miyata, Kenji, Usui, Makoto, Kadokami, Toshiaki, Tashiro, Hideki, Morishige, Kunio, Hironaga, Kiyoshi, Tsutsui, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Circulation Society
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329913/ https://www.ncbi.nlm.nih.gov/pubmed/37435100 http://dx.doi.org/10.1253/circrep.CR-23-0047 |
Ejemplares similares
-
Association of Serum Oxysterols with Cholesterol Metabolism Markers and Clinical Factors in Patients with Coronary Artery Disease: A Covariance Structure Analysis
por: Akiyama, Yusuke, et al.
Publicado: (2023) -
Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial
por: Nakano, Yasuhiro, et al.
Publicado: (2023) -
Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in
Apoe
(−/−)
Mice
por: Katsuki, Shunsuke, et al.
Publicado: (2022) -
The Functional Severity Assessment of Coronary Stenosis Using Coronary Computed Tomography Angiography-Based Myocardial Mass at Risk and Minimal Lumen Diameter
por: Sadamatsu, Kenji, et al.
Publicado: (2020) -
Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)